NCT06704451

Brief Summary

Perioperative neurocognitive dysfunction(PND) are common complications of major surgery among patients, could be a long-term disease, which sometimes lasts for several years, and it is meaningful to find a biomarker of PND at the early stage.As far as we know, the relationship between IL-33 and PND is not clear yet in the gastrointestinal and hepatic area. Thus, the investigators designed this study to find out the association between IL-33 and occurrence of PND, and determine whether IL-33 could be a biomarker of the early stage of PND.Study population included 150 subjects. Neuropsychological questionnaire were administrated one day before surgery and three days after surgery. And the end of the operation peripheral venous blood was sampled to measure IL-33 inflammatory protein expression in peripheral blood monocytes. Analyze the data and draw conclusions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 18, 2014

Completed
10.2 years until next milestone

First Submitted

Initial submission to the registry

October 27, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 26, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

November 26, 2024

Status Verified

October 1, 2024

Enrollment Period

10.8 years

First QC Date

October 27, 2024

Last Update Submit

November 24, 2024

Conditions

Keywords

Interleukin-33Postoperative Neurocognitive DysfunctionPostoperative ComplicationsInflammasomes

Outcome Measures

Primary Outcomes (1)

  • The association between peripheral blood IL-33 inflammasome level and postoperative cognitive dysfunction

    Postoperative cognitive dysfunction (POCD) was defined by Z scores. The method of Z scores is as follows: A patient was defined as having POCD when two Z scores in individual tests or the combined Z score were 2 or more. Neuropsychological tests included MMSE,Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised,Trail Making Test, Digital Scope Test,Word Delayed Recall Test, Word Delayed Interference Test, Image Delayed Recall Test. Preoperative scores were compared with postoperative test results, subtracted the average practice effect from these changes, and then divided the result by the control-subject standard deviation to obtain a Z score for each test. The Z scores of all tests in an individual patient were then summarized and divided by the standard deviation for this sum of Z scores in the control subjects, creating a combined Z score. The test results were adjusted so that a positive Z score indicated deterioration from the baseline test.

    Expected completion date: June 18, 2025

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Abdominal surgery patients

You may not qualify if:

  • history of mental diseases;
  • patients with current Neurological disease;
  • patients who refused or were unable to finish the neurocognitive evaluation;
  • preoperative Mini-Mental Stare Examination (MMSE) less than required score (illiteracy \<17; primary school \< 20; middle school and higher \< 24).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The first affiliated hospital of KUNMING medical university

Kunming, Yunnan, 650032, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

plasma

MeSH Terms

Conditions

Cognitive DysfunctionPostoperative Complications

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of The first affiliated hospital of KUNMING medical university

Study Record Dates

First Submitted

October 27, 2024

First Posted

November 26, 2024

Study Start

August 18, 2014

Primary Completion

June 18, 2025

Study Completion

December 30, 2025

Last Updated

November 26, 2024

Record last verified: 2024-10

Locations